Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 10:58 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 49–72 of 125 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Hospital Admission Clear all

Conditions: Bronchiolitis, Infection, Nitric Oxide
Interventions: Not listed
Lead sponsor: NYU Langone Health; Other
Eligibility: Up to 4 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Mineola, New York

Conditions: Congestive Heart Failure
Interventions: Not listed
Lead sponsor: Mayo Clinic; Other
Eligibility: 65 Years and older
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2005
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Sepsis, Septic Shock, Sepsis With Acute Organ Dysfunction
Interventions: Not listed
Lead sponsor: Axis Shield Diagnostics Ltd; Industry
Eligibility: 18 Years and older
Enrollment: 571 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 5
States / cities: Philadelphia, Pennsylvania • York, Pennsylvania • Nashville, Tennessee + 1 more

Conditions: SIRS, Balanced Fluids, Plasmalyte
Interventions: Not listed
Lead sponsor: Baxter Healthcare Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 1,558 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Deerfield, Illinois

Conditions: Anemia
Interventions: placebo, epoetin alpha, Niferex; Drug
Lead sponsor: University of Medicine and Dentistry of New Jersey; Other
Eligibility: 60 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 2
States / cities: Cranbury, New Jersey • East Brunswick, New Jersey

Conditions: Type 2 Diabetes Mellitus
Interventions: insulin aspart, insulin detemir; Drug
Lead sponsor: Rush University Medical Center; Other
Eligibility: 18 Years to 80 Years
Enrollment: 176 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Hospital Admission, Length of Stay
Interventions: Not listed
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Cellulitis
Interventions: teledermatology consult, Routine Care; Other
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Patient Education
Interventions: CPR video; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 65 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Acute Chest Pain, NSTEMI - Non-ST Segment Elevation MI
Interventions: European Society of Cardiology hs-cTnT/I 0 h/1 h algorithm, European Society of Cardiology hs-cTnT/I 0 h/3 h algorithm; Diagnostic Test
Lead sponsor: University Hospital, Basel, Switzerland; Other
Eligibility: 18 Years and older
Enrollment: 64,374 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2028
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Doula Support, Postpartum, Postpartum Depression (PPD), Postpartum Anemia
Interventions: Doula-delivered, Nurse-coordinated postpartum support; Behavioral
Lead sponsor: University of South Carolina; Other
Eligibility: 18 Years and older · Female only
Enrollment: 350 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Columbia, South Carolina

Conditions: Residual Paralysis, Post-Anesthesia
Interventions: Quantitative measurement of neuromuscular transmission; Procedure
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 3,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2017
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Sickle Cell Disease, Vaso-occlusive Crisis, Vaso-occlusive Pain Episode in Sickle Cell Disease
Interventions: Inclacumab, Placebo; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 12 Years and older
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 17
States / cities: Mobile, Alabama • Phoenix, Arizona • Little Rock, Arkansas + 11 more

Conditions: Vitamin D Deficiency
Interventions: Not listed
Lead sponsor: Cooper Norcross Health; Other
Eligibility: 18 Years and older
Enrollment: 9,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Camden, New Jersey

Conditions: Hypertension, Hypotension
Interventions: ACEI or ARB; Drug
Lead sponsor: State University of New York - Downstate Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 188 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Brooklyn, New York

Conditions: Muscle Weakness, Critical Illness
Interventions: Not listed
Lead sponsor: Naeem Ali, MD; Other
Eligibility: 18 Years and older
Enrollment: 170 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 5
States / cities: Indianapolis, Indiana • Cincinnati, Ohio • Cleveland, Ohio + 1 more

Conditions: Malnutrition, Sarcopenia
Interventions: Not listed
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 65 Years and older
Enrollment: 190 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2024
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Hyperglycemia
Interventions: BG Test; Procedure
Lead sponsor: HealthPartners Institute; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2004
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: COVID-19
Interventions: Ramipril 2.5 MG Oral Capsule, Placebo oral capsule; Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Covid19, Coronavirus Infection, Pneumonia
Interventions: Antibiotic; Drug
Lead sponsor: National Institutes of Health Clinical Center (CC); NIH
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Community Reinforcement And Family Training, Family Health, Substance-Related Disorders
Interventions: Community Reinforcement And Family Training, We The Village Peer Community Forum; Behavioral
Lead sponsor: We The Village, Inc.; Other
Eligibility: 19 Years and older
Enrollment: 212 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Diabetes
Interventions: Not listed
Lead sponsor: University of Central Florida; Other
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Occupational Accidents, Incubation Period, Infectious Disese
Interventions: Not listed
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 3 Years to 99 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2011
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Cellulitis
Interventions: teledermatology consult, Routine Care; Other
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Columbus, Ohio

Search by objective public record fields.

Exhaled Nitric Oxide Levels in Infants and Young Children Infected With RSV or Other Viral Infections

BNP Measurement Reduces Resource Utilization for Patients With CHF Admitted Thorough the ED

Assessment of Heparin Binding Protein for the Prediction of Severe Sepsis

Effects of IV Chloride Content on Outcomes

Prevalence and Treatment of Anemia in Rehabilitation Patients

Management of Diabetes in the Emergency Room: a Randomized Trial of an Insulin Protocol.

A Study of Emergency Department AI Prediction Impact

Effect of Teledermatology on Length of Hospital Admission, Length of Stay, 30 Day Readmission Rate, and Antibiotic Use in Patients Presenting With Cellulitis vs Pseudocellulitis in an Academic ED Setting

Feasibility of a Standardized Video for Patient Education and as a Decision Aid on Code Status for Patients in the Emergency Department Pending Admission to the Hospital

Emergency Department Triage of Patients With Acute Chest Pain Based on the ESC 0/1-hour Algorithm (PRESC1SE-MI)

The Goal is to Examine the Impact of Doula-delivered, Nurse-coordinated Postpartum Care Among Individuals With Preterm Births <34 Weeks' Gestation Requiring NICU Admission.

Effects of Postoperative Residual Paralysis on Hospital Costs

A Study of a Single Dose of Inclacumab to Reduce Re-admission in Participants With Sickle Cell Disease and Recurrent Vaso-occlusive Crises

Emulated Study of Vitamin D Correction Vs Non-Correction

ACEI/ARB Study in Ambulatory and Day of Surgery Admission Patients

New Onset Weakness in Critically Ill Patients and the Risk of Death and Recurrent ICU Admission

Prevalence of Malnutrition and/or Sarcopenia at Hospital Admission

Admission Glucose ICU Study

Ramipril for the Treatment of COVID-19

Utility of Empiric Antibiotics for Non-intubated Novel Coronavirus Diseases 2019 Patients

Scalable Digital Delivery of Evidence-based Training for Family to Maximize Treatment Admission Rates of Opioid Use Disorder in Loved Ones

Capability Assessment for Diet and Activity (CADA) Model for Diabetes

Admission and Management of Occupational or Other Exposures to Biodefense/Bioterrorism Agents or to Epidemic/Emerging Infectious Diseases

The Effect of Dermatology and Teledermatology Consultations on Length of Hospital Admission, 30 Day Readmission Rate, and Antibiotic Use in Patients Presenting With Cellulitis vs Pseudocellulitis in an Academic Inpatient Setting